Gap junctions: The 'kiss of death' and the 'kiss of life'

Brain Research Reviews

Volumn 32, Issue 1, 2000, Pages 308-315

  Andrade Rozental, A F ^a   Rozental, R ^a,b   Hopperstad, M G ^a   Wu, J K ^c   Vrionis, F D ^c   Spray, D C ^a,b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

^c TUFTS MEDICAL CENTER   (United States)

Author keywords

Apoptosis; Bystander effect; Cx32; Cx37; Cx40; Cx43; Gap junction; Good Samaritan effect; Intercellular communication

Indexed keywords

GANCICLOVIR; GAP JUNCTION PROTEIN; THYMIDINE KINASE;

ANIMAL CELL; APOPTOSIS; CELL COMMUNICATION; CELL DEATH; CYTOTOXICITY; GAP JUNCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SHORT SURVEY;

EID: 0034108850     PISSN: 01650173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0173(99)00099-5     Document Type: Review

References (49)

1. Alemany R., Gomez-Manzano C., Balague C., Yung W.K.A., Curiel D.T., Kyritsis A.P., Fueyo J.H. Gene therapy for gliomas: molecular targets, adenoviral vectors, and oncolytic adenoviruses. Exp. Cell Res. 252:1999;1-12.
2. Allen R.T., Hunter W.J. III, Agrawal D.K. Morphological and biochemical characterization and analysis of apoptosis. J. Pharmacol. Toxicol. Methods. 37:1997;215-228.
3. Alley M.C., Scudiero D.A., Monks A., Hursey M.L., Czerwinski M.J., Fine D.L., Abbott B.J., Mayo J.G., Shoemaker R.H., Boyd M.R. Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res. 48:1988;589-601.
4. Alley M.C., Pacula-Cox C.M., Hursey M.L., Rubinstein L.R., Boyd M.R. Morphometric and colorimetric analyses of human tumor cell line growth and drug sensitivity in soft agar culture. Cancer Res. 51:1991;1247-1256.
5. Barba D., Hardin J., Ray J., Gage F.H. Thymidine kinase-mediated killing of rat brain tumors. J. Neurosurg. 79:1993;729-735.
6. Barba D., Hardin J., Sadelain M., Gage F.H. Development of anti-tumor immunity following thymidine kinase-mediated killing of experimental brain tumors. Proc. Natl. Acad. Sci. U. S. A. 91:1994;4348-4352.
7. Bi W.L., Parysek L.M., Warnick R., Stambrook P.J. In vitro evidence that metabolic cooperation is responsible for the bystander effect observed with HSV tk retroviral gene therapy. Hum. Gene Ther. 4:1993;725-731.
8. Burk R.R., Subak-Sharpe J.H., Pitts J.D. Exchange between hamster cells in culture. Exp. Cell Res. 53:1968;297-301.
9. Chiu F.-C., Potter P.E., Rozental R. Purification of human fetal hippocampal neurons by flow cytometry for transplantation. Methods. 16:1998;260-267.
10. Crumpacker C.S., Ganciclovir N. Engl. J. Med. 335:1996;721-729.
11. Culver K.W., Ram Z., Wallbridge I.H., Oldfield E.H., Blasé R.M. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science. 256:1992;1550-1552.
12. Z. Darzynkiewics, H.A. Crissman, in: Z. Darzynkiewics, H.A. Crissman (Eds.), Methods in Cell Biology, Academic Press, San Diego, CA, 1990, pp. xv-xvii.
13. Elshami A.A., Saavedra A., Zhang H., Kucharczuk J.C., Spray D.C., Fishman G.I., Amin K.M., Kaiser L.R., Albelda S.M. Gap junctions play a role in the "bystander effect" of the herpes simplex virus thymidine kinase/ganciclovir system in vitro. Gene Ther. 3:1996;85-92.
14. Estin D., Li M., Spray D.C., Wu J.K. Connexins are expressed in primary brain tumors and enhance the bystander effect in gene therapy. Neurosurgery. 44:1999;361-368.
15. Fick J., Barker F.G. II, Dazin P., Westphale E.M., Beyer E.C., Israel M.A. The extent of heterocellular communication mediated by gap junctions is predictive of bystander tumor cytotoxicity in vitro. Proc. Natl. Acad. Sci. U. S. A. 92:1995;11071-11075.
16. Freeman S.M., Abboud C.N., Whartenby K., Packman C.H., Koeplin D.S., Moolten F.L., Abraham G.N. The "bystander effect": tumor regression when a fraction of the tumor mass is genetically modified. Cancer Res. 53:1993;5274-5283.
17. Fujimoto W.Y., Subak-Sharpe J.H., Seegmiller J.E. Hypoxanthine-guanine phosphoribosyltransferase deficiency: chemical agents selective for mutant or normal cultured fibroblasts in mixed and heterozygote cultures. Proc. Natl. Acad. Sci. U. S. A. 68:1971;1516-1519.
18. Holder J.W., Elmomre E., Barrett J.C. Gap junction function and cancer. Cancer Res. 53:1993;3475-3485.
19. Hotz-Wagenblatt A., Shalloway D. Gap junctional communication and neoplastic transformation. Oncogenesis. 4:1993;541-558.
20. Kolberg R. The bystander effect in gene therapy: great, but how does it work? J. NIH Res. 6:1994;62-64.
21. Koopman G., Reutelingsperger C.P., Kuijten G.A., Keehnen R.M., Pals S.T., van Oers M.H. Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood. 84:1994;1415-1420.
22. Loewenstein W.R., Rose B. The cell-cell channel in the control of growth. Semin. Cell Biol. 3:1992;59-79.
23. Mesnil M., Piccoli C., Tiraby G., Willecke K., Yamasaki H. Bystander killing of cancer cells by herpes simplex virus thymidine kinase gene mediated by connexins. Proc. Natl. Acad. Sci. 93:1996;1831-1835.
24. Moolten F.L., Wells J.M. Curability of tumors bearing herpes thymidine kinase genes transferred by retroviral vectors. J. Natl. Cancer Inst. 82:1990;297-300.
25. Naus C.C., Elsevich K., Zhu D.J., Belliveau D., Del Maestro R.F. In vivo growth of C6 glioma cells transfected with connexin43 cDNA. Cancer Res. 52:1992;4208-4213.
26. Pitts J.D. The discovery of metabolic cooperation. BioEssays. 20:1998;1047-1051.
27. Ram Z., Culver K.W., Walbridge S., Blaese R.M., Oldfield E.H. In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats. Cancer Res. 53:1993;83-88.
28. Rimon G., Bazenet C.E., Philpott K.L., Rubin L.L. Increased surface phosphatidylserine is an early marker of neuronal apoptosis. J. Neurosci. Res. 15:1997;563-570.
29. Rozental R., Gebhard D., Padin C., Urban M., Wu J.Y., Spray D.C., Chiu F.-C. Purification of cell populations from human fetal brain using flow cytometric techniques. Dev. Brain Res. 85:1995;161-170.
30. R. Rozental, M. Srinivas, D.C. Spray, How to close a gap junction channel: efficacies and potencies of uncoupling agents, in: R. Bruzzone, C. Giaume (Eds.), Connexin Methods and Protocols, Humana Press, 1999 (in press).
31. Samejima Y., Meruelo D. Bystander killing induces apoptosis and is inhibited by forskolin. Gene Ther. 2:1995;50-58.
32. D.C. Spray, E. Scemes, R. Rozental, Cell-cell communication via gap junctions, in: Zigmond, Bloom, Landis, Roberts, Squire (Eds.), Fundamental Neuroscience, Academic Press, New York, NY, 1998, pp. 317-343.
33. Staub F., Mackert B., Kempski O., Peters J., Baethmann A. Swelling and death of neuronal cells by lactic acid. J. Neurol. Sci. 119:1993;79-84.
34. Subak-Sharpe H. Biochemically marked variants of the Syrian hamster fibroblast cell line in BHK21 and its derivatives. Exp. Cell Res. 38:1965;106-119.
35. Subak-Sharpe H., Burk R.R., Pitts J.D. Metabolic co-operation by cell to cell transfer between genetically different mammalian cells in culture. Heredity. 21:1966;342-343.
36. Szybalski E.H., Szbalski W. Genetics of human cell lines: IV. DNA-mediated hereditable transformation of a biochemical trait. Proc. Natl. Acad. Sci. U. S. A. 48:1962;2026-2034.
37. Szybalski W. Use of the HPRT gene and the HAT selection technique in DNA mediated transformation of mammalian cells: first steps towards developing hybridoma techniques and gene therapy. BioEssays. 14:1992;495-500.
38. Van Engeland M., Kuijpers H.J., Ramaekers F.C., Reutelingsperger C.P., Schutte B. Plasma membrane alterations and cytoskeletal changes in apoptosis. Exp. Cell Res. 235:1997;421-430.
39. Vermes I., Haanen C., Steffens-Nakken H., Reutelingsperger C. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labeled Annexin V. J. Immunol. Methods. 184:1995;39-51.
40. Vrionis F.D., Wu J.K., Qi P., Cano W., Cherington V. A more potent bystander cytocidal effect elicited by tumor cells expressing the herpes simplex virus-thymidine kinase gene than by fibroblast virus-producer cells in vitro. J. Neurosurg. 83:1995;698-704.
41. Vrionis F.D., Wu J.K., Qi P., Waltzman M., Cherington V., Spray D.C. The bystander effect exerted by tumor cells expressing the herpes simplex virus thymidine kinase (HSVtk) gene is dependent on connexin expression and cell communication via gap junctions. Gene Ther. 4:1997;577-585.
42. Wu J., Cano W.G., Meylaerts S.A., Qi P., Vrionis F., Cherington V. Bystander tumoricidal effect in treatment of experimental brain tumors. Neurosurgery. 35:1994;1094-1103.
43. Wygoda M.R., Wilson M.R., Davis M.A., Trosko J.E., Rehemtulla A., Lawrence T.S. Protection of herpes simplex virus thymidine kinase-transduced cells from ganciclovir-mediated cytotoxicity by bystander cells: the good Samaritan effect. Cancer Res. 57:1997;1699-1703.
44. Yamasaki H., Krutovskikh V., Mesnil M., Tanaka T., Zaidan-Dagli M.L., Omori Y. Role of connexin (gap junction) genes in cell growth control and carcinogenesis. C. R. Acad. Sci., Ser. III. 322:1999;151-159.
45. Yamasaki H. Gap junctional intercellular communication and carcinogenesis. Carcinogenesis. 11:1990;1051-1058.
46. Yamasaki H., Omori Y., Krutovskikh V., Zhu W., Moronov N., Yamakage K., Mesnil M. Connexins in tumor suppression and cancer therapy. Novartis Found. Symp. 219:1999;241-254. discussion 254-260.
47. Zhang G., Gurtu V., Kain S.R., Yan G. Early detection of apoptosis using a fluorescent conjugate of annexin V. BioTechniques. 23:1997;525-531.
48. Zhu D., Caveney S., Kidder G.M., Naus C.C. Transfection of C6 glioma cells with connexin 43 cDNA: analysis of expression, intercellular coupling, and cell proliferation. Proc. Natl. Acad. Sci. U. S. A. 88:1991;1883-1887.
49. Zhu D., Kidder G.M., Caveney S., Naus C.C. Growth retardation in glioma cells cocultured with cells overexpressing a gap junction protein. Proc. Natl. Acad. Sci. U. S. A. 89:1992;10218-10221.